Maxivet

Maxi-Vet is a Belgian biotechnology company specializing in regenerative medicine for veterinary applications, primarily focusing on horses and dogs. The company operates a specialized laboratory dedicated to the isolation, cultivation, and characterization of adipose-derived mesenchymal stem cells (ASCs) to treat various orthopedic conditions. Their therapeutic portfolio includes autologous stem cell treatments and platelet-rich plasma (PRP) therapies designed to address indications such as osteoarthritis, tendon lesions, and ligament injuries. By providing these advanced biological solutions to veterinary surgeons, Maxi-Vet aims to enhance the natural healing process and improve long-term clinical outcomes for animals with musculoskeletal injuries.